Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene
about
Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator geneThe transcription factor p53: not a repressor, solely an activator{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligasep53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencingThe ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translationInsulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysMethylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathwaysThe rebel angel: mutant p53 as the driving oncogene in breast cancer.Emerging Non-Canonical Functions and Regulation by p53: p53 and StemnessInsulin-like growth factor system in cancer: novel targeted therapiesRegulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogeneOxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitmentModulation of mammalian life span by the short isoform of p53.Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes.Antagonistic pleiotropy and p53.Running on empty: how p53 controls INS/IGF signaling and affects life spanData on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assayTranslation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site.Regeneration associated growth factor receptor and epithelial marker expression in lymphoid aggregates of ulcerative colitis.Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting ApproachesMutant p53 gain-of-function in cancer.Nuclear factor kappaB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene.Molecular and genetic aspects of lung cancer.Targeting insulin-like growth factor axis in hepatocellular carcinoma.Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4Amplification of the insulin-like growth factor 1 receptor gene is a rare event in adrenocortical adenocarcinomas: searching for potential mechanisms of overexpressionp53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia.ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response.Mechanisms by which IGF-I may promote cancerSomething old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulationMutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cellsAssociation between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer.Δ40 Isoform of p53 controls β-cell proliferation and glucose homeostasis in mice.Insulin-like growth factor system and sporadic malignant melanoma.Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cellsToca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
P2860
Q22009375-F017BB98-13C5-434C-A46F-30ACE8DDF85EQ24273295-8C0EB3CB-C93F-4246-9960-08BEF16B4DE5Q24301549-146282BC-A616-4740-BBC6-3A46EC5254DAQ24533238-0971F32F-BABE-4CA4-950E-656D6BC1791DQ24550864-AF888717-791E-4418-AD69-D04913385313Q24794247-46BB723B-6077-4FFE-A835-9612AB896633Q26742114-E97547FF-19A5-4418-ADD9-D0DC6E6B9DF8Q27306870-D40A56FB-0E76-426F-9ABE-5BA0523F2C15Q27686765-1D7BACE1-737F-44C6-8854-7C546EB9F0F5Q28077156-211B7D8D-760B-4E73-8B8D-63CB2072490AQ28081603-0FC906F3-E98C-4BE9-9795-24068168F250Q28143662-1D5126C1-376D-4F9F-A803-2E83F74F7D48Q28575421-55182488-6AA4-45C5-A1DD-A4782DF82DD1Q30312095-FE19EDA4-255C-431C-A5E8-02D9E6A3108FQ30411254-208342D1-2E00-4CFD-9B51-204DE917B6FDQ30437532-EE9F080D-717A-4A3F-8FA9-A1C2BC33BB21Q30446473-7341039F-F7D3-44C0-BD01-FF7F3D32E59EQ31137353-3EAFE301-35DD-428C-976D-936E63B01C50Q31527528-66CFD320-A23B-401F-882D-0A53CAB233F8Q33529463-25482302-BC53-44F9-886C-9E21AF5920C2Q33570283-AF5B1251-24D4-43F7-845D-117273422495Q33588231-C20A2111-E982-4D92-87CE-D409C2AF9711Q33658023-7E7814D6-94CC-4335-880D-FE3DD66D00AAQ33687048-D2CEF6E3-266A-4A39-B4D7-1AFD9C437726Q33744690-2574F152-765C-4539-9BFB-BF32C27E8E4AQ33891465-9AF83B67-C34A-4853-8DAF-7449ADE47C1EQ33951057-FA475D10-B2C5-49F4-B419-838E399ECF5FQ33988397-CF9CDE22-C54F-414F-A2FE-7262B58E7CFDQ33993253-BC59C16D-8710-40AB-86D1-A3059766EBEDQ34093124-CFFA9AA5-D558-49E0-BFAD-58286801FFC7Q34098413-299A0E8C-B3D0-4FD6-94E3-C44C9E26CE79Q34180961-4397D0CF-6E5E-4961-83E8-45A9AE47D9F9Q34387886-24DF51E4-F7A5-4254-81BC-4CBCE2DD7DADQ34480997-D59B3A2F-C0E6-4F37-B647-0717079D1F34Q34515619-151D6290-11CF-451D-833C-410F2DA6C1C9Q34718783-1F92F44D-0941-4D19-A98D-CF86F9E3D36EQ34756364-D77BFD74-A904-44D2-B2EA-900FE931346BQ34792237-9BD796A3-C139-4FF5-8072-C430C326EB41Q35012773-3E74CEA4-92AE-4C8D-B576-BF4A73C054B6Q35095843-9C7DC784-D8D0-49D3-872E-04EDCC51CB23
P2860
Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene
description
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1996
@ast
im August 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/08/06)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/08/06)
@nl
наукова стаття, опублікована в серпні 1996
@uk
name
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@ast
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@en
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@nl
type
label
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@ast
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@en
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@nl
prefLabel
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@ast
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@en
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@nl
P2093
P2860
P3181
P356
P1476
Wild-type and mutant p53 diffe ...... growth factor I receptor gene
@en
P2093
D. LeRoith
E. Karnieli
F. J. Rauscher
P2860
P304
P3181
P356
10.1073/PNAS.93.16.8318
P407
P577
1996-08-06T00:00:00Z